Blog
Docusign: Another Beat, Another Selloff—Why the Analysts Are Wrong
Key Points
- Interested in Docusign Inc.? Here are five stocks we like better.
- DocuSign shares are selling off after June 4 earnings despite beating estimates, raising guidance, and reporting solid
Meta Unveils Subscriptions: A New Offering With Real Growth Potential
Key Points
- Interested in Meta Platforms, Inc.? Here are five stocks we like better.
- Meta Platforms stock has struggled to generate and hold returns so far in 2026.
- This comes as investors
BASF Bets on China Growth as Zhanjiang Site Targets €5 Billion in Sales by 2030
Key Points
- Interested in Basf Se? Here are five stocks we like better.
- BASF’s new Zhanjiang Verbund site in Guangdong has started operations on schedule and below budget, marking the company’s
3 Longevity ETFs to Buy and Hold (and Hold)
Key Points
- Interested in SPDR S&P Biotech ETF? Here are five stocks we like better.
- The longevity industry is expected to nearly triple in size from 2025 to 2035, creating growing interest from
The Market May Be Missing What’s Changing at BigBear AI
Key Points
- Interested in BigBear.ai Holdings, Inc.? Here are five stocks we like better.
- BigBear AI's stock price chart is bullish, showing a strong Head & Shoulders Reversal.
- Coverage and
CME Group CEO Blasts Bitcoin Perpetual Futures, Warns of ‘2007’ Risk
Key Points
- Interested in CME Group Inc.? Here are five stocks we like better.
- CME CEO Terry Duffy slammed the CFTC’s approval of a Bitcoin perpetual futures contract, arguing that perpetuals
Chime Financial CEO Maps Growth Roadmap, $2.7B Revenue Target at Conference
Key Points
- Interested in Chime Financial, Inc.? Here are five stocks we like better.
- Chime CEO Chris Britt said the company is focused on building primary checking relationships with mainstream
CG Oncology Touts Cretostimogene Data, BLA Progress in Bladder Cancer Push
Key Points
- Interested in CG Oncology, Inc.? Here are five stocks we like better.
- CG Oncology said its lead bladder cancer therapy, cretostimogene, has shown encouraging efficacy in
Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference
Key Points
- Interested in Certara, Inc.? Here are five stocks we like better.
- Certara is reorganizing around two growth engines — ACE for accelerating clinical evidence and MID3 for
These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
Key Points
- Interested in MetLife, Inc.? Here are five stocks we like better.
- Commercial property and casualty insurance premiums fell 1.2% in Q1 2026, the first quarterly decline since 2017
Celsius Plots Energy Drink Comeback as Alani, Rockstar Deals Reshape Growth
Key Points
- Interested in Celsius Holdings Inc.? Here are five stocks we like better.
- Celsius is reshaping into a multi-brand energy platform as it integrates Alani and Rockstar, with CEO John
Petco Faces Tough Competition, But Momentum Is Building
Key Points
- Interested in Petco Health and Wellness Company, Inc.? Here are five stocks we like better.
- Petco Health and Wellness is in the midst of a turnaround and is reducing debt.
- Free cash
The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Key Points
- Interested in D.R. Horton, Inc.? Here are five stocks we like better.
- The housing lock-in effect continues to restrict existing home inventory as many homeowners remain unwilling to
CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies
Key Points
- Interested in CareDx, Inc.? Here are five stocks we like better.
- CareDx posted strong Q1 results, with revenue up 39% year over year and Testing Services volume up 17%. The company
Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam
Key Points
- Interested in Bruker Corporation? Here are five stocks we like better.
- Order momentum is improving across Bruker’s business, with semiconductor metrology, overseas
Black Rock Coffee Bar Targets 1,000 Stores as Loyalty Fuels Growth Plan
Key Points
- Interested in Black Rock Coffee Bar, Inc.? Here are five stocks we like better.
- Black Rock Coffee Bar said it is targeting 1,000 stores by 2035, with management aiming for about 20%
Backblaze Sees AI Boom Fueling Cloud Storage Demand and Neocloud Deals
Key Points
- Interested in Backblaze, Inc.? Here are five stocks we like better.
- Backblaze says AI demand is reshaping its business, with customers looking for storage that can work across
Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
Key Points
- Interested in Samsara Inc.? Here are five stocks we like better.
- Samsara delivered another strong earnings report, reinforcing its status as one of the most consistent execution
Blackbaud Touts AI Agents, Payments Growth and Buybacks at Baird Conference
Key Points
- Interested in Blackbaud, Inc.? Here are five stocks we like better.
- Blackbaud executives said the company is leaning into AI with a three-wave strategy that includes analytics
IREN's 800MW Bet Flips the AI Power Switch
Key Points
- Interested in IREN Limited? Here are five stocks we like better.
- The strategic acquisition of grid-connected real estate empowers IREN Limited to supply massive electrical capacity to
BlackLine Says AI Agents, Platform Pricing Can Reignite Revenue Growth
Key Points
- Interested in BlackLine? Here are five stocks we like better.
- BlackLine says it can reignite revenue growth by pushing platform pricing, broader enterprise adoption and new AI agent
CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
Key Points
- Interested in CrowdStrike? Here are five stocks we like better.
- CrowdStrike's stock fell after earnings despite beating revenue and EPS estimates, raising guidance, and posting record
Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Key Points
- Interested in Tesla, Inc.? Here are five stocks we like better.
- The termination of federal EV tax credits ahead of schedule has contributed to U.S. EV sales falling 27% year over year
BioAge Labs Eyes Key BGE-102 Readouts in Heart Risk and Diabetic Eye Disease
Key Points
- Interested in BioAge Labs, Inc.? Here are five stocks we like better.
- BioAge Labs said its lead drug BGE-102 is on track for near-term data in two areas: a Phase 2 cardiovascular
MarketBeat Week in Review – 06/01 - 06/05
Key Points
- Interested in Dollar General Corporation? Here are five stocks we like better.
- Stocks sold off sharpy to end the week with money moving out of technology stocks and into many of the